Aktuellt
SENASTE
Redeye is positive that Bioservo has registered Carbonhand as a medical-technical product according to the 510(k) exemption. This progress has come earlier than expected and means that Bioservo can now start marketing Carbonhand in the US, and work to set up the partner structure can be initiated. This is a milestone for the company as the US market has the most significant potential for these products. Sales in the US will realistically commence in 2024e, and Bioservo will now work to get the appropriate reimbursement codes in place (Healthcare Procedure Coding System). Bioservo is tomorrow publishing its Q1’23 report before the market opens.
LÄS MER
